MOLECULAR INEQUALITY IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) AND IMPLICATIONS FOR CLINICAL TRIALS

被引：0
|
作者：
Naidoo, Jarushka [1 ]
Noonan, Sinead [2 ]
Teo, Min Yuen [3 ]
Rho, Young Soo [1 ]
Clince, Janet [1 ]
Gately, Kathy [4 ]
O'Grady, Tony [5 ]
Kaye, Elaine [5 ]
Calvert, Paula [6 ]
Morris, Patrick G. [7 ]
O'Brien, Cathal [4 ]
O'Byrne, Kenneth [8 ]
Breathnach, Oscar S. [1 ]
机构：
[1] Beaumont Hosp, Dublin, Ireland
[2] St James Hosp, Dublin, Ireland
[3] Inc Natl Childrens Hosp, Adelaide & Meath Hosp, Dublin 24, Ireland
[4] Univ Dublin Trinity Coll, Dublin 2, Ireland
[5] Beaumont Hosp, Dublin, Ireland
[6] Waterford Reg Hosp, Waterford, Ireland
[7] Hermitage Clin, Dublin, Ireland
[8] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Treatment; non-small cell lung cancer; Cinical Trials; Inequality;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-042
引用
收藏
页码：S1208 / S1208
页数：1
相关论文
共 50 条
  • [1] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Ramírez, JL
    Sancho, E
    Núñez, L
    Sánchez, JJ
    Balañá, C
    López, P
    Martín, C
    Monzó, M
    Rosell, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S39 - S39
  • [2] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Pifarre, A
    Monzo, M
    Martin, C
    Sanchez, JJ
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
  • [3] Treatment delays in non-small cell lung cancer (NSCLC) and their prognostic implications
    Diaconescu, R.
    Lafond, C.
    Choiniere, L.
    Sirois, C.
    Laliberte, B.
    Doyon, M.
    Whittom, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] TREATMENT DELAYS IN NON-SMALL CELL LUNG CANCER (NSCLC) AND THEIR PROGNOSTIC IMPLICATIONS
    Diaconescu, R.
    Lafond, C.
    Choiniere, L.
    Sirois, C.
    Laliberte, B.
    Doyon, M.
    Whittom, R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S112 - S112
  • [5] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [6] MOLECULAR MARKERS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Heigener, D.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1979 - 1979
  • [7] Evaluation of clinical and molecular changes in advanced non-small cell lung cancer(NSCLC)
    Pilnik, N
    Di Rienzo, J
    Spitale, L
    Grasso, R
    Henin, A
    Caminos, S
    LUNG CANCER: CURRENT TOPICS, 2001, : 65 - 70
  • [8] The cost of non-small cell lung cancer (NSCLC) treatment
    Vergnenegre, A.
    ONCOLOGIE, 2012, 14 (05) : 310 - 315
  • [9] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
    Garcia-Campelo, R.
    Bernabe, R.
    Cobo, M.
    Corral, J.
    Coves, J.
    Domine, M.
    Nadal, E.
    Rodriguez-Abreu, D.
    Vinolas, N.
    Massuti, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 1020 - 1029
  • [10] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013
    C. Camps
    E. Felip
    R. García-Campelo
    J. M. Trigo
    P. Garrido
    Clinical and Translational Oncology, 2013, 15 : 977 - 984
12345